about
Genome-wide review of transcriptional complexity in mouse protein kinases and phosphatases.Pancreatic cancer genomes reveal aberrations in axon guidance pathway genesInternational network of cancer genome projects.MicroRNAs and their isomiRs function cooperatively to target common biological pathwaysUse of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriersPGTools: A Software Suite for Proteogenomic Data Analysis and Visualization.Use of DNA-damaging agents and RNA pooling to assess expression profiles associated with BRCA1 and BRCA2 mutation status in familial breast cancer patients.Lost in translation: returning germline genetic results in genome-scale cancer researchWhole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma.Returning individual research results for genome sequences of pancreatic cancer.qpure: A tool to estimate tumor cellularity from genome-wide single-nucleotide polymorphism profilesPoint Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.The expression of the ubiquitin ligase SIAH2 (seven in absentia homolog 2) is mediated through gene copy number in breast cancer and is associated with a basal-like phenotype and p53 expressionSomatic point mutation calling in low cellularity tumors.Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib.PINA v2.0: mining interactome modules.Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.Whole genomes redefine the mutational landscape of pancreatic cancer.Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinomaA comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing.RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies.Identification of the CIMP-like subtype and aberrant methylation of members of the chromosomal segregation and spindle assembly pathways in esophageal adenocarcinoma.A Common Variant at the 14q32 Endometrial Cancer Risk Locus Activates AKT1 through YY1 BindingRecurrent inactivating RASA2 mutations in melanoma.Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT Dysregulation.Neuropilin-2 promotes extravasation and metastasis by interacting with endothelial α5 integrinMicroarray-based DNA profiling to study genomic aberrations.Mitochondrial mutations and metabolic adaptation in pancreatic cancer.Clinical and molecular characterization of HER2 amplified-pancreatic cancer.The clinical potential and challenges of sequencing cancer genomes for personalized medical genomics.Sequencing transcriptomes in toto.Understanding pancreatic cancer genomes.Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage.Mutational signatures in esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance.Genomic analyses identify molecular subtypes of pancreatic cancer.Unexpected UVR and non-UVR mutation burden in some acral and cutaneous melanomas.Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma.A workflow to increase verification rate of chromosomal structural rearrangements using high-throughput next-generation sequencing.A2AR adenosine signaling suppresses natural killer cell maturation in the tumor microenvironment.
P50
Q24548067-535A4643-CC24-4281-B5AE-9AD0BB7A000AQ24595981-DF54D525-05A8-4DF6-B2E3-BA7522F8E725Q24611474-B161B865-8FF6-4A74-9BC9-913F76E793AEQ27499590-E99E2399-C2BE-484A-8282-7662B8095905Q28261738-6965F218-5A63-4E0C-94E9-F6A9F4DDFC49Q30908583-C9128C10-661E-4E18-B368-4C84828D4AFCQ33533295-7D19CF61-D66F-4469-AF75-5037DBC8A291Q33613050-59B44F26-65D5-4576-A43A-D1A81C534425Q33755896-C9E7D6BD-9930-4427-88CE-3F5734E80948Q33796388-10E53F22-DC8E-434F-8AD4-2735CBFECAA8Q34438482-450B7BB8-E9F1-4958-9966-A93368F470B4Q34522502-22698168-4CB6-47CC-B960-2795434003BCQ35029589-14F82020-52C1-42F2-B775-56D7A0E4EB0FQ35046527-1FCEB9D8-B1F6-467D-AC71-8FACC4929BABQ35602598-15DCA075-9E5D-4385-9F71-C18CF9D3FF4FQ35630696-C4DC03D8-F9BB-49AB-9079-CABFDFF152FDQ35685370-9A8ED3AF-13C2-4C15-9309-5804C5FA4F5EQ35911034-D6072EE4-04FC-4A80-84B3-8FADE28545BEQ35925026-6602B9E3-2F42-4043-8821-12B31C4E4BDCQ36379244-84B8F40E-C192-4C5F-A2D2-19F8A5486359Q36512097-E5AD4C5D-1ABD-4C27-BE85-8C334F563330Q36725997-056A8CF7-6E7F-4E96-AA00-0F65E1DA4523Q37005064-8806C563-B093-4DD4-BDA1-2C7A01A38781Q37112088-9469FA7F-0A27-4365-8418-B151FC9C4B53Q37170296-89177A13-BEDE-4AFF-A790-E13927647B05Q37175886-7955E105-352C-41F9-81E7-3734ADF43793Q37191173-1A760890-D31D-4288-87A1-5DA7163D51EEQ37615978-00A3AEF3-A59D-49E3-BB24-CB1331512820Q37690146-A5B81607-8256-44AE-861D-567BC6E13CA7Q37806700-799E8491-98A8-4063-98A2-D70465BB1700Q37836418-A9B596B4-82E3-4539-9503-3575DDAE2F04Q38105473-FCD10420-4BF5-4514-A208-DCFCCF298B34Q38640565-89DA0A67-A45A-4125-881E-C516CAD224F0Q38748208-C4511706-0C7B-4BE8-B0DA-F4255CE69552Q38791499-416C2176-C826-45DD-BFFA-FC24B604A230Q39031930-FC63C147-3494-4168-BDF1-9D9BD50048A4Q40113311-5AA2B78D-5539-48EF-8457-FD07275E31DEQ40211104-5E49B34E-1FBC-4389-BBFD-551E5A59F830Q45058812-80D28068-344E-41FB-A03C-7133EC7B1F6EQ46011796-1400BAB7-32E6-4283-B33A-A8F19BDF960C
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-3950-2476
@en
name
Nicola J Waddell
@ast
Nicola J Waddell
@en
Nicola J Waddell
@es
Nicola J Waddell
@nl
type
label
Nicola J Waddell
@ast
Nicola J Waddell
@en
Nicola J Waddell
@es
Nicola J Waddell
@nl
altLabel
Nicola Waddell
@en
prefLabel
Nicola J Waddell
@ast
Nicola J Waddell
@en
Nicola J Waddell
@es
Nicola J Waddell
@nl
P106
P21
P31
P496
0000-0002-3950-2476